SCOPUS 정보 검색 플랫폼

Volumn 30, Issue SUPPL. 1, 1997, Pages 62-64

International guidelines on post-authorisation research and surveillance

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; EUROPE; LAW; PRIORITY JOURNAL; RESEARCH; SHORT SURVEY; STANDARDIZATION;

EID: 0031018120 PISSN: 01763679 EISSN: None Source Type: Journal
DOI: 10.1055/s-2007-979519 Document Type: Short Survey

Times cited : (10)

References (10)

1
- 7344262211
- Arbeitsgruppe der Deutschen Region der Internationalen Biometrischen Gesellschaft, Herbold M. et al.: Empfehlungen zur Planung, Durchführung und Auswertung von Anwendungsbeobachtungen (1994)
- (1994) Empfehlungen zur Planung, Durchführung und Auswertung von Anwendungsbeobachtungen
- Herbold, M.¹

2
- 0028122995
- Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie, Linden, M. et al.: Richtlinien zur Durchführung von Anwendungsbeobachtungen. Nervenarzt 65 (1994) 638-644
- (1994) Richtlinien zur Durchführung von Anwendungsbeobachtungen. Nervenarzt , vol.65 , pp. 638-644
- Linden, M.¹

3
- 7344251612
- Association Brit. Pharm. Industry (ABPI): Guidelines for phase IV clinical trials (1993)
- (1993) Guidelines for Phase IV Clinical Trials

4
- 7344261721
- Guidelines on post-marketing surveillance
- Association Brit. Pharm. Industry ABPI et al.: Guidelines on post-marketing surveillance. In: Brit. Med. J. 297 (1988) 142
- (1988) Brit. Med. J. , vol.297 , pp. 142

5
- 5544239581
- Merkblatt für Anwendungsbeobachtungen
- Bundesverband der Pharm. Industrie BPI: Merkblatt für Anwendungsbeobachtungen. Pharm. Ind. 52 (1991) 529
- (1991) Pharm. Ind. , vol.52 , pp. 529

6
- 0343905325
- Draft III/5994/94
- Commission of the European Communities: Notice to applicants for marketing authorisations for medical products for human use in European Community. Draft III/5994/94 (1994)
- (1994) Notice to Applicants for Marketing Authorisations for Medical Products for Human Use in European Community

7
- 7344235238
- III/3176/93 draft 3
- Committee for Proprietary Medicinal Products CPMP: Guideline for marketing authorisation holders on company-sponsored post-marketing safety studies. III/3176/93 (1993) draft 3
- (1993) Guideline for Marketing Authorisation Holders on Company-sponsored Post-marketing Safety Studies

8
- 7344252907
- Committee for Proprietary Medicinal Products: Guideline for marketing authorisation holders on ongoing pharmacovigilance evaluation during the post-marketing period (1993)
- (1993) Guideline for Marketing Authorisation Holders on Ongoing Pharmacovigilance Evaluation during the Post-marketing Period

9
- 0028557946
- The SAMM guidelines - Guidelines for company sponsored safety assessment of marketed medicines
- Medicines Control Agency MCA et al.: The SAMM guidelines - Guidelines for company sponsored safety assessment of marketed medicines. In: Pharmacoepid. Drug. Safety 3 (1994) 1-6
- (1994) Pharmacoepid. Drug. Safety , vol.3 , pp. 1-6

10
- 0006902837
- Springer, Berlin
- Victor, N. et al.: Arzneimittelforschung nach der Zulassung - Bestandsaufnahme und Perspektiven. Springer, Berlin (1991)
- (1991) Arzneimittelforschung Nach der Zulassung - Bestandsaufnahme und Perspektiven
- Victor, N.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.